ISPOR - PRM34 - FRENCH EFFICIENCY OPINIONS OF THE ECONOMIC AND PUBLIC HEALTH COMMITTEE (CEESP)- IS THERE AN IMPACT ON THE MARKET ACCESS FOR INNOVATIVE DRUGS?

Full Text

PRM34 - FRENCH EFFICIENCY OPINIONS OF THE ECONOMIC AND PUBLIC HEALTH COMMITTEE (CEESP)- IS THERE AN IMPACT ON THE MARKET ACCESS FOR INNOVATIVE DRUGS?

Abstract

Authors

P Schiele F Porte S Bénard

Back to Volume 21, Supplemental S3

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now